Markt geschlossen· · CHF · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
Investing.com -- European medtech has had another bruising year, with only Demant and Sonova outperforming the Stoxx 600 in 2026 as the sector’s once-premium valuation continues to de-rate.
IART vs. SONVY: Which Stock Is the Better Value Option?
STAFA, SWITZERLAND - June 16, 2026 (NEWMEDIAWIRE) - Sonova Holding AG (SWX: SOON), the leading provider of innovative hearing care solutions, announces the results of its 41st Annual General Meeting (AGM), held today. The shareholders approved al...
SONVY vs. IDXX: Which Stock Is the Better Value Option?
As the European markets experience a wave of optimism with major indexes like the STOXX Europe 600 Index climbing 2.27%, investors are keenly observing opportunities that may be trading below their fair value amid strengthening economic signals from key economies like Germany. Identifying stocks that are undervalued requires careful analysis of market conditions, company fundamentals, and potential for growth in a landscape where interest rates remain favorable and industrial production shows...
Amid optimism about the European economy and favorable interest rate conditions, major stock indexes across the region have experienced gains, with Germany's DAX and France's CAC 40 Index showing notable increases. In this environment of strengthening economic indicators, identifying stocks that may be priced below their intrinsic value can offer strategic opportunities for investors seeking to capitalize on potential market inefficiencies.
Sonova Holding AG (SONVF) reports robust sales growth in Hearing Instruments and Audiological Care, while facing headwinds in Consumer Hearing and Cochlear Implants.
Aktuelle Schlagzeilen Dritter zu diesem Unternehmen, getrennt von Makklers eigener Redaktion und mit Verlinkung zum Herausgeber. Für die Richtigkeit ist der jeweilige Herausgeber verantwortlich.